Arrowstreet Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Arrowstreet Capital’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.8K	Buy	+20,252	New	+$78K	﹤0.01%	1806
2022 Q2	–	Sell	-17,623	Closed	-$50K	–	1258
2022 Q1	$50K	Sell	17,623 -3,615	-17%	-$12K	﹤0.01%	1147
2021 Q4	$99K	Buy	+21,238	New	+$72.4K	﹤0.01%	1395
2021 Q3	–	Sell	-10,700	Closed	-$30K	–	1628
2021 Q2	$30K	Hold	10,700	–	–	﹤0.01%	1821
2021 Q1	$32K	Buy	+10,700	New	+$34.8K	﹤0.01%	2198

Other funds holding CPIX

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital's CPIX Position: Q1 2026 in Review

Arrowstreet Capital opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 20,252 shares worth $65.8K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in CPIX as recently as Q1 2022.

Arrowstreet Capital first reported a position in CPIX in Q1 2021 and has held it in 5 quarters since. The position peaked at $99K in Q4 2021. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

Arrowstreet Capital held 20,252 shares of Cumberland Pharmaceuticals worth $65.8K as of Q1 2026.
Cumberland Pharmaceuticals was a new Arrowstreet Capital position in Q1 2026.
Cumberland Pharmaceuticals made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1806 holding.
Arrowstreet Capital first reported a position in Cumberland Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
Arrowstreet Capital's Cumberland Pharmaceuticals position peaked at $99K in Q4 2021.
29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.